Abstract
- The introduction of RTS, S/AS01 Malaria vaccine to children aged 5-17months in areas of medium to high transmission of malaria was recommended pending;
-
- Review of real data, other groups work and other countries that has piloted RTS, S/AS01 to inform on duration and effectiveness of vaccine and timing of vaccination to ensure protection below five years of age.
- The availability of data on the gaps in waning of immunity before a child reach five years
- Intensive social mobilization and acceptability studies regarding RTS. S/AS01
-
- The Government should facilitate registration and sustainable availability of RTS, S/AS01 malaria vaccines due low production capacity of vaccine by manufacturer
- The government to ensure sustainable funding to sustain existing malaria interventions as outlined in National Malaria Strategic Plan 2020–2025 that have significantly contributed to reduction of Malaria in the country
- Community and other stakeholders should be mobilized to understand the benefits of RTS, S/AS01 vaccine and other Malaria interventions.
- Recommendation
- Africa
- Tanzania (United Republic Of)
- Children
- Malaria